Omalizumab and allergen immunotherapy in a patient with asthma and inhaled corticosteroid-induced adrenal suppression

Ann Allergy Asthma Immunol. 2016 Sep;117(3):335-7. doi: 10.1016/j.anai.2016.07.017.

Authors

Jason T Forbush¹, Taylor A Banks²

Affiliations

¹ National Capital Consortium Pediatrics Residency, Walter Reed National Military Medical Center, Bethesda, Maryland. Electronic address: Jason.T.Forbush2.mil@mail.mil.
² Allergy, Immunology, and Immunization Service, Walter Reed National Military Medical Center, Bethesda, Maryland.

PMID: 27613470
DOI: 10.1016/j.anai.2016.07.017

No abstract available

Publication types

Case Reports

MeSH terms

Adrenal Cortex Hormones / adverse effects*
Adrenal Cortex Hormones / therapeutic use
Allergens / immunology*
Anti-Asthmatic Agents / therapeutic use*
Asthma / drug therapy*
Asthma / immunology*
Asthma / metabolism
Child
Desensitization, Immunologic / methods
Drug-Related Side Effects and Adverse Reactions / drug therapy*
Drug-Related Side Effects and Adverse Reactions / immunology
Humans
Male
Omalizumab / therapeutic use*

Substances

Adrenal Cortex Hormones
Allergens
Anti-Asthmatic Agents
Omalizumab